Bimatoprost
Active pharmaceutical substance formulated in Jan Aushadhi generic products for Eye & Ear Care treatment.
🧴 Clinical Application
Instill one drop into the affected eye(s) once daily in the evening. Wipe away excess solution from the eyelid margins to prevent unwanted periorbital hyperpigmentation and periocular hair growth. Remove contact lenses before use.
⚠️ Side Effects
Common: Conjunctival hyperemia, ocular pruritus, iris hyperpigmentation (permanent), eyelash growth, periorbital fat atrophy (deepening of eyelid sulcus), dry eyes. Rare/Severe: Cystoid macular edema, iritis, and exacerbation of asthma (if combined with timolol).
🛡️ Safety Warnings
May cause permanent iris pigmentation changes and reversible periorbital fat loss (sunken eye appearance). Contraindicated in patients with active intraocular inflammation (uveitis/iritis). Discard bottle 4 weeks after opening.
Jan Aushadhi Products containing Bimatoprost
Found 3 generic formulation(s) containing this active ingredient.
Bimatoprost Ophthalmic Solution 0.01% w/v
Bimatoprost (0.01%, 0.03% w/v, alone or with Timolol 0.5%) is a synthetic prostamide (cyclopentane amide) ocular hypotensive agent on the WHO Model List of Essential Medicines. It structurally mimics endogenous prostamides, binding to unique prostamide receptors to simultaneously increase both trabecular meshwork and uveoscleral aqueous humor outflow, achieving powerful intraocular pressure reduction. Indicated for the reduction of elevated intraocular pressure in open-angle glaucoma and ocular hypertension.
Bimatoprost Ophthalmic Solution 0.03% w/v
Bimatoprost (0.01%, 0.03% w/v, alone or with Timolol 0.5%) is a synthetic prostamide (cyclopentane amide) ocular hypotensive agent on the WHO Model List of Essential Medicines. It structurally mimics endogenous prostamides, binding to unique prostamide receptors to simultaneously increase both trabecular meshwork and uveoscleral aqueous humor outflow, achieving powerful intraocular pressure reduction. Indicated for the reduction of elevated intraocular pressure in open-angle glaucoma and ocular hypertension.
Bimatoprost 0.03% w/v + Timolol 0.5% w/v Ophthalmic Solution
Bimatoprost (0.01%, 0.03% w/v, alone or with Timolol 0.5%) is a synthetic prostamide (cyclopentane amide) ocular hypotensive agent on the WHO Model List of Essential Medicines. It structurally mimics endogenous prostamides, binding to unique prostamide receptors to simultaneously increase both trabecular meshwork and uveoscleral aqueous humor outflow, achieving powerful intraocular pressure reduction. Indicated for the reduction of elevated intraocular pressure in open-angle glaucoma and ocular hypertension.
Brand Equivalents & Price Comparison
Compare Jan Aushadhi generic prices against popular commercial brands for Bimatoprost.
| Generic Formulation | Pack Size | Jan Aushadhi Price | Commercial Brand Equivalents | Avg. Commercial Price | Savings |
|---|---|---|---|---|---|
| Bimatoprost Ophthalmic Solution 0.01% w/v | 3 ml | Under Process | N/A | N/A | N/A |
| Bimatoprost Ophthalmic Solution 0.03% w/v | 3 ml | ₹159.38 | CAREPROST | ₹546.83 | 71% Save |
| Bimatoprost 0.03% w/v + Timolol 0.5% w/v Ophthalmic Solution | 5ml Drops | ₹159.38 | N/A | N/A | N/A |
Frequently Asked Questions (FAQ)
Get answers to common queries about Bimatoprost generics.